Viracta Therapeutics, Inc.
VIRX
$0.022
-$0.0048-17.91%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 3.00M | 3.04M | 3.92M | 4.15M | 4.32M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 10.19M | 9.59M | 13.88M | 13.56M | 12.48M |
| Operating Income | -10.19M | -9.59M | -13.88M | -13.56M | -12.48M |
| Income Before Tax | -10.55M | -9.83M | -9.14M | -13.77M | -12.60M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -10.55M | -9.83M | -9.14M | -13.77M | -12.60M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -10.55M | -9.83M | -9.14M | -13.77M | -12.60M |
| EBIT | -10.19M | -9.59M | -13.88M | -13.56M | -12.48M |
| EBITDA | -10.08M | -9.49M | -13.77M | -13.44M | -12.35M |
| EPS Basic | -0.27 | -0.25 | -0.23 | -0.35 | -0.33 |
| Normalized Basic EPS | -0.17 | -0.16 | -0.15 | -0.22 | -0.20 |
| EPS Diluted | -0.27 | -0.25 | -0.23 | -0.35 | -0.33 |
| Normalized Diluted EPS | -0.17 | -0.16 | -0.15 | -0.22 | -0.20 |
| Average Basic Shares Outstanding | 39.57M | 39.41M | 39.32M | 38.79M | 38.68M |
| Average Diluted Shares Outstanding | 39.57M | 39.41M | 39.32M | 38.79M | 38.68M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
